Hematopoietic stem cell transplantation (HSCT) is a medical procedure employed to treat diverse blood and bone marrow disorders, including certain genetic conditions and autoimmune diseases. The process entails replacing a patient's damaged or diseased bone marrow with healthy stem cells obtained from a donor. These transplanted stem cells then grow and generate new blood cells within the patient's body. The stem cells for transplantation can be sourced from bone marrow, peripheral blood, or umbilical cord blood.
The primary types of cells used in hematopoietic stem cell transplantation are allogeneic and autologous. Allogeneic transplants involve stem cells obtained from a donor with a different genetic makeup than the recipient. This type of transplantation is applied to address conditions such as leukemia, lymphatic disorders, myeloma, and others. The applications include bone marrow transplants, peripheral blood stem cell transplants, and cord blood transplants. Hematopoietic stem cell transplantation is utilized by various end-users, including hospital pharmacies, retail pharmacies, and specialty clinics.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The hematopoietic stem cell transplantation market research report is one of a series of new reports from The Business Research Company that provides hematopoietic stem cell transplantation market statistics, including hematopoietic stem cell transplantation industry global market size, regional shares, competitors with a hematopoietic stem cell transplantation market share, detailed hematopoietic stem cell transplantation market segments, market trends and opportunities, and any further data you may need to thrive in the hematopoietic stem cell transplantation industry. This hematopoietic stem cell transplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from $4.68 billion in 2024 to $5.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, emergence of allogeneic transplants, regulatory milestones.
The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $7.7 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to expanded treatment indications, donor source diversification, personalized medicine and genomics, regulatory changes and guidelines, market expansion and accessibility. Major trends in the forecast period include advancements in transplant techniques, expansion of indications, emerging cellular therapies, donor diversification, precision medicine approach.
The forecast of 10.8% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. transplant programs by inflating prices of cell processing systems and cryopreservation media developed in Switzerland and Japan, resulting in delayed life-saving procedures and higher bone marrow transplant costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The anticipated surge in the occurrence of blood cancer is set to drive the growth of the hematopoietic stem cell transplantation market. Blood cancers encompass a group of malignancies affecting the development and functioning of blood cells, including leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation is a common treatment for these conditions, involving the replacement of stem cells and bone marrow cells damaged by the malignancy. These transplanted stem cells migrate to the bone marrow, initiating the production of new blood cells. In August 2022, Blood Cancer UK reported 41,000 identified blood cancer cases annually in the UK, making it the sixth most prevalent cancer. With an estimated 250,000 people affected in 2022, including over 500 children, the increased incidence of blood cancer drives the hematopoietic stem cell transplantation market.
The burgeoning aging population is expected to contribute to the growth of the hematopoietic stem cell transplantation market. The aging population, defined as individuals aged 65 and older, finds hematopoietic stem cell transplantation a viable treatment for various hematological disorders. As a notable example, the World Health Organization projected that globally, one in six people would be 60 or older by 2030, with the number doubling to 2.1 billion by 2050. In the UK, it is anticipated that by 2043, 24% of the total population (17.4 million people) will be seniors. Consequently, the expanding aging population propels the hematopoietic stem cell transplantation market.
Product approvals emerge as a prominent trend in the hematopoietic stem cell transplantation market, with major companies securing regulatory clearances to sustain their market positions. For instance, in April 2022, Ireland-based Priothera Ltd. received FDA clearance for an investigational new drug (IND) to initiate a Phase IIb/III research study with mocravimod in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant. Mocravimod, a synthetic sphingosine 1-phosphate receptor (S1PR) modulator, demonstrated safety and efficacy in earlier trials for various autoimmune diseases.
Leading companies in hematopoietic stem cell transplantation are concentrating on developing innovations such as digital resources to optimize patient management, improve donor matching processes, and offer real-time data analytics for enhanced decision-making. Digital resources encompass various online tools, platforms, or materials that deliver information, services, or functionalities in a digital format. For example, in September 2024, BioLineRx Ltd., a biopharmaceutical company based in Israel, introduced Mobilization Matters, a digital resource designed to educate healthcare professionals and patients about the mobilization of stem cells for transplantation. This interactive platform provides comprehensive guidelines, best practices, and real-time tracking tools to enhance the stem cell collection process, ultimately improving patient outcomes and ensuring the efficient use of resources in transplantation procedures.
In August 2022, France-based Eurobio Scientific Group acquired Netherlands-based Genome Diagnostics B.V. for $132.3 million, enhancing Eurobio's commercial portfolio for evaluating compatibility in organ and marrow transplants, further solidifying its position in the hematopoietic stem cell transplantation market.
Major companies operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd.
North America was the largest region in the hematopoietic stem cell transplantation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the hematopoietic stem cell transplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The hematopoietic stem cell transplantation (HSCT) market includes revenues earned by entities providing services such as medical evaluation, pre-transplant care, stem cell collection and processing, transplantation procedures, post-transplant care, supportive care, and long-term follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hematopoietic Stem Cell Transplantation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hematopoietic stem cell transplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hematopoietic stem cell transplantation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hematopoietic stem cell transplantation market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Allogeneic; Autologous
- 2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders
- 3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant
- 4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
- Subsegments:
- 1) By Allogeneic: Matched Related Donor Transplantation; Matched Unrelated Donor Transplantation; Cord Blood Transplantation
- 2) By Autologous: Peripheral Blood Stem Cell Transplantation; Bone Marrow Stem Cell Transplantation
- Companies Mentioned: Pluristem Therapeutics Inc.; Lonza Group AG; Escape Therapeutics Inc.; Regen Biopharma Inc.; Bluebird Bio Inc.; CellGenix GmbH; CBR Systems Inc.; Merck KGaA; Cord Blood Corporation; Kiadis Pharma NV; Marker Therapeutics Inc.; Taiga Biotechnologies Inc.; Takeda Pharmaceutical Company Limited; Talaris Therapeutics Inc.; ViaCord LLC; ScienCell Research Laboratories Inc.; BiolineRx; Stemcell Technologies Inc.; ThermoGenesis Holdings Inc.; MEDIPOST Co. Ltd.; Anterogen. Co. Ltd.; Pharmicell Inc.; JCR Pharmaceuticals Co. Ltd.; Holostem Terapie Avanzate Srl; Regrow Biosciences Pvt Ltd.; Stempeutics Research Pvt Ltd.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time Series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hematopoietic Stem Cell Transplantation Market Characteristics
3. Hematopoietic Stem Cell Transplantation Market Trends And Strategies
4. Hematopoietic Stem Cell Transplantation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Hematopoietic Stem Cell Transplantation Growth Analysis And Strategic Analysis Framework
- 5.1. Global Hematopoietic Stem Cell Transplantation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Hematopoietic Stem Cell Transplantation Market Growth Rate Analysis
- 5.4. Global Hematopoietic Stem Cell Transplantation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Hematopoietic Stem Cell Transplantation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Hematopoietic Stem Cell Transplantation Total Addressable Market (TAM)
6. Hematopoietic Stem Cell Transplantation Market Segmentation
- 6.1. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Allogeneic
- Autologous
- 6.2. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Leukemia
- Lymphatic Disorder
- Myeloma
- Other Non-Malignant Disorders
- 6.3. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Bone Marrow Transplant
- Peripheral Blood Stem Cell Transplant
- Cord Blood Transplant
- 6.4. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospital Pharmacy
- Retail Pharmacy
- Specialty Clinics
- 6.5. Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Allogeneic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Matched Related Donor Transplantation
- Matched Unrelated Donor Transplantation
- Cord Blood Transplantation
- 6.6. Global Hematopoietic Stem Cell Transplantation Market, Sub-Segmentation Of Autologous, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Peripheral Blood Stem Cell Transplantation
- Bone Marrow Stem Cell Transplantation
7. Hematopoietic Stem Cell Transplantation Market Regional And Country Analysis
- 7.1. Global Hematopoietic Stem Cell Transplantation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Hematopoietic Stem Cell Transplantation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Hematopoietic Stem Cell Transplantation Market
- 8.1. Asia-Pacific Hematopoietic Stem Cell Transplantation Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Hematopoietic Stem Cell Transplantation Market
- 9.1. China Hematopoietic Stem Cell Transplantation Market Overview
- 9.2. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Hematopoietic Stem Cell Transplantation Market
- 10.1. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Hematopoietic Stem Cell Transplantation Market
- 11.1. Japan Hematopoietic Stem Cell Transplantation Market Overview
- 11.2. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Hematopoietic Stem Cell Transplantation Market
- 12.1. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Hematopoietic Stem Cell Transplantation Market
- 13.1. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Hematopoietic Stem Cell Transplantation Market
- 14.1. South Korea Hematopoietic Stem Cell Transplantation Market Overview
- 14.2. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Hematopoietic Stem Cell Transplantation Market
- 15.1. Western Europe Hematopoietic Stem Cell Transplantation Market Overview
- 15.2. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Hematopoietic Stem Cell Transplantation Market
- 16.1. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Hematopoietic Stem Cell Transplantation Market
- 17.1. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Hematopoietic Stem Cell Transplantation Market
- 18.1. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Hematopoietic Stem Cell Transplantation Market
- 19.1. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Hematopoietic Stem Cell Transplantation Market
- 20.1. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Hematopoietic Stem Cell Transplantation Market
- 21.1. Eastern Europe Hematopoietic Stem Cell Transplantation Market Overview
- 21.2. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Hematopoietic Stem Cell Transplantation Market
- 22.1. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Hematopoietic Stem Cell Transplantation Market
- 23.1. North America Hematopoietic Stem Cell Transplantation Market Overview
- 23.2. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Hematopoietic Stem Cell Transplantation Market
- 24.1. USA Hematopoietic Stem Cell Transplantation Market Overview
- 24.2. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Hematopoietic Stem Cell Transplantation Market
- 25.1. Canada Hematopoietic Stem Cell Transplantation Market Overview
- 25.2. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Hematopoietic Stem Cell Transplantation Market
- 26.1. South America Hematopoietic Stem Cell Transplantation Market Overview
- 26.2. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Hematopoietic Stem Cell Transplantation Market
- 27.1. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Hematopoietic Stem Cell Transplantation Market
- 28.1. Middle East Hematopoietic Stem Cell Transplantation Market Overview
- 28.2. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Hematopoietic Stem Cell Transplantation Market
- 29.1. Africa Hematopoietic Stem Cell Transplantation Market Overview
- 29.2. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Hematopoietic Stem Cell Transplantation Market Competitive Landscape And Company Profiles
- 30.1. Hematopoietic Stem Cell Transplantation Market Competitive Landscape
- 30.2. Hematopoietic Stem Cell Transplantation Market Company Profiles
- 30.2.1. Pluristem Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Escape Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Regen Biopharma Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Bluebird Bio Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Hematopoietic Stem Cell Transplantation Market Other Major And Innovative Companies
- 31.1. CellGenix GmbH
- 31.2. CBR Systems Inc.
- 31.3. Merck KGaA
- 31.4. Cord Blood Corporation
- 31.5. Kiadis Pharma NV
- 31.6. Marker Therapeutics Inc.
- 31.7. Taiga Biotechnologies Inc.
- 31.8. Takeda Pharmaceutical Company Limited
- 31.9. Talaris Therapeutics Inc.
- 31.10. ViaCord LLC
- 31.11. ScienCell Research Laboratories Inc.
- 31.12. BiolineRx
- 31.13. Stemcell Technologies Inc.
- 31.14. ThermoGenesis Holdings Inc.
- 31.15. MEDIPOST Co. Ltd.
32. Global Hematopoietic Stem Cell Transplantation Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Hematopoietic Stem Cell Transplantation Market
34. Recent Developments In The Hematopoietic Stem Cell Transplantation Market
35. Hematopoietic Stem Cell Transplantation Market High Potential Countries, Segments and Strategies
- 35.1 Hematopoietic Stem Cell Transplantation Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Hematopoietic Stem Cell Transplantation Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Hematopoietic Stem Cell Transplantation Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
